Entera Bio Ltd. (ENTX) is a clinical-stage biopharmaceutical company headquartered in Jerusalem, Israel, that is pioneering innovative oral delivery systems for large molecule therapeutics. Focusing on substantial unmet medical needs, the company leverages its proprietary platform to enhance patient compliance and broaden therapeutic options. Entera Bio's promising pipeline features advanced therapies designed to improve the efficacy and accessibility of treatments, thus positioning the company as a significant contributor to the advancement of biopharmaceuticals. With a commitment to revolutionizing healthcare solutions, Entera Bio is poised to transform therapeutic administration and patient outcomes.
Click "Analyze" to generate stock analysis
ENTX Price Trend and Signals
ENTX Option Volumes & Open Interests (aggregated)
ENTX Put Call Ratios and IV (aggregated)
ENTX Financials
2025-10-29Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-29Somewhat Bullishprice_signal
Yearly high detected.
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-13Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-10Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.